Fed. Circ. Forecast: Kite Takes Aim At Juno's $1.2B IP Win
The Federal Circuit next week will hear Kite Pharma's appeal of a $1.2 billion verdict in favor of Juno Therapeutics in a case over a cancer treatment patent, marking the first...To view the full article, register now.
Already a subscriber? Click here to view full article